Research progress of transcatheter aortic valve replacement-related new valve prostheses_West China Medical Journal

Authors：

KONG Xiangquan , GAO Xiaofei , ZHANG Juan , WANG Zhimei , GE Zhen ,  ZHANG Junjie

Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210001, P. R. China;

Corresponding author：

ZHANG Junjie, Email: jameszll@163.com

Keywords：

Transcatheter aortic valve replacement; transcatheter heart valve; aortic valve stenosis; aortic valve regurgitation

DOI：

10.7507/1002-0179.202308091

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Transcatheter aortic valve replacement has revolutionized the management of aortic stenosis and become the gold standard for the treatment of symptomatic and severe aortic valve stenosis in elderly patients. With the improvement in design and materials, newer generation transcatheter aortic valve prostheses had overcome the limitations of early-generation devices that were susceptible to paravalvular leak, atrioventricular block and vascular complications, to a certain extent. This review provides an update on the latest advances in transcatheter aortic valve prostheses.

Citation： KONG Xiangquan, GAO Xiaofei, ZHANG Juan, WANG Zhimei, GE Zhen, ZHANG Junjie. Research progress of transcatheter aortic valve replacement-related new valve prostheses. West China Medical Journal, 2023, 38(9): 1309-1313. doi: 10.7507/1002-0179.202308091 Copy

1.	Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2.	Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
3.	Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-2516.
4.	Xu H, Liu Q, Cao K, et al. Distribution, characteristics, and management of older patients with valvular heart disease in China: China-DVD Study. JACC Asia, 2022, 2(3): 354-365.
5.	Cannata S, Gandolfo C, Ribichini FL, et al. One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry. EuroIntervention, 2023, 18(17): 1418-1427.
6.	Nazif TM, Cahill TJ, Daniels D, et al. Real-world experience with the SAPIEN 3 Ultra transcatheter heart valve: a propensity-matched analysis from the United States. Circ Cardiovasc Interv, 2021, 14(9): e010543.
7.	Tang GHL, Zaid S, Michev I, et al. “Cusp-overlap” view simplifies fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2018, 11(16): 1663-1665.
8.	Doldi PM, Stolz L, Escher F, et al. Transcatheter aortic valve replacement with the self-expandable Core Valve Evolut prosthesis using the cusp-overlap vs. tricusp-view. J Clin Med, 2022, 11(6): 1561.
9.	Gada H, Vora AN, Tang GHL, et al. Site-level variation and predictors of permanent pacemaker implantation following TAVR in the Evolut low-risk trial. Cardiovasc Revasc Med, 2023, 47: 48-54.
10.	Khera S, Krishnamoorthy P, Sharma SK, et al. Improved commissural alignment in TAVR with the newest Evolut FX self-expanding supra-annular valve: first-in-human experience. JACC Cardiovasc Interv, 2023, 16(4): 498-500.
11.	Merdler I, Case B, Bhogal S, et al. Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVR. Cardiovasc Revasc Med, 2023: S1553-8389(23)00627-9.
12.	Makkar RR, Cheng W, Waksman R, et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet, 2020, 396(10252): 669-683.
13.	Sondergaard L, Walton AS, Worthley SG, et al. Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study. EuroIntervention, 2023, 19(3): 248-255.
14.	Tamburino C, Bleiziffer S, Thiele H, et al. Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial. Circulation, 2020, 142(25): 2431-2442.
15.	Buono A, Gorla R, Ielasi A, et al. Transcatheter aortic valve replacement with self-expanding ACURATE neo2: postprocedural hemodynamic and short-term clinical outcomes. JACC Cardiovasc Interv, 2022, 15(11): 1101-1110.
16.	Zhou D, Pan W, Wang J, et al. VitaFlow^TM transcatheter valve system in the treatment of severe aortic stenosis: one-year results of a multicenter study. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
17.	杨力凡, 张晓春, 张蕾, 等. VitaFlow^TM 经导管瓣膜系统治疗重度主动脉瓣狭窄—多中心 2 年随访结果. 中国介入心脏病学杂志, 2020, 28(6): 316-320.
18.	宋光远, 王墨扬, 王媛, 等. Venus-A 主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果. 中华心血管病杂志, 2017, 45(10): 843-847.
19.	Wang M, Song G, Chen M, et al. Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis. EuroIntervention, 2022, 17(13): 1070-1076.
20.	Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol, 2017, 70(22): 2752-2763.
21.	Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. Ann Thorac Surg, 2021, 111(2): 701-722.
22.	Kempfert J, Rastan AJ, Mohr FW, et al. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve^TM. Eur J Cardiothorac Surg, 2011, 40(3): 761-763.
23.	Nijenhuis VJ, Swaans MJ, Michiels V, et al. “First experience with JenaValve^TM: a single-centre cohort”. Neth Heart J, 2015, 23(1): 35-41.
24.	Schäfer U, Schirmer J, Niklas S, et al. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EuroIntervention, 2017, 13(11): 1296-1299.
25.	Vahl T, Makkar R, Kodali S, et al. 30-day outcomes of transfemoral transcatheter aortic valve replacement for aortic regurgitation with a novel self-expanding prosthesis. J Am Coll Cardiol, 2021, 77(18): 919.
26.	Shi J, Wei L, Chen Y, et al. Transcatheter aortic valve implantation with J-Valve: 2-year outcomes from a multicenter study. Ann Thorac Surg, 2021, 111(5): 1530-1536.
27.	Hensey M, Murdoch DJ, Sathananthan J, et al. First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system. EuroIntervention, 2019, 14(15): e1553-e1555.
28.	Rezvova MA, Yuzhalin AE, Glushkova TV, et al. Biocompatible nanocomposites based on poly(styrene-block-isobutylene-block-styrene) and carbon nanotubes for biomedical application. Polymers (Basel), 2020, 12(9): 2158.
29.	Rezvova MA, Nikishau PA, Makarevich MI, et al. Biomaterials based on carbon nanotube nanocomposites of poly(styrene-b-isobutylene-bstyrene): the effect of nanotube content on the mechanical properties, biocompatibility and hemocompatibility. Nanomaterials, 2022, 12(5): 733.
30.	Bui HT, Khair N, Yeats B, et al. Transcatheter heart valves: a biomaterials perspective. Adv Healthc Mater, 2021, 10(15): 2100115.
31.	Li RL, Russ J, Paschalides C, et al. Mechanical considerations for polymeric heart valve development: biomechanics, materials, design and manufacturing. Biomaterials, 2019, 225: 119493.
32.	Oveissi F, Naficy S, Lee A, et al. Materials and manufacturing perspectives in engineering heart valves: a review. Mater Today Bio, 2020, 5: 100038.
33.	Kereiakes DJ, Answini GA, Yakubov SJ, et al. Preliminary evaluation of a novel polymeric valve following surgical implantation for symptomatic aortic valve disease. JACC Cardiovasc Interv, 2021, 14(24): 2754-2756.

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
3. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-2516.
4. Xu H, Liu Q, Cao K, et al. Distribution, characteristics, and management of older patients with valvular heart disease in China: China-DVD Study. JACC Asia, 2022, 2(3): 354-365.
5. Cannata S, Gandolfo C, Ribichini FL, et al. One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry. EuroIntervention, 2023, 18(17): 1418-1427.
6. Nazif TM, Cahill TJ, Daniels D, et al. Real-world experience with the SAPIEN 3 Ultra transcatheter heart valve: a propensity-matched analysis from the United States. Circ Cardiovasc Interv, 2021, 14(9): e010543.
7. Tang GHL, Zaid S, Michev I, et al. “Cusp-overlap” view simplifies fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2018, 11(16): 1663-1665.
8. Doldi PM, Stolz L, Escher F, et al. Transcatheter aortic valve replacement with the self-expandable Core Valve Evolut prosthesis using the cusp-overlap vs. tricusp-view. J Clin Med, 2022, 11(6): 1561.
9. Gada H, Vora AN, Tang GHL, et al. Site-level variation and predictors of permanent pacemaker implantation following TAVR in the Evolut low-risk trial. Cardiovasc Revasc Med, 2023, 47: 48-54.
10. Khera S, Krishnamoorthy P, Sharma SK, et al. Improved commissural alignment in TAVR with the newest Evolut FX self-expanding supra-annular valve: first-in-human experience. JACC Cardiovasc Interv, 2023, 16(4): 498-500.
11. Merdler I, Case B, Bhogal S, et al. Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVR. Cardiovasc Revasc Med, 2023: S1553-8389(23)00627-9.
12. Makkar RR, Cheng W, Waksman R, et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet, 2020, 396(10252): 669-683.
13. Sondergaard L, Walton AS, Worthley SG, et al. Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study. EuroIntervention, 2023, 19(3): 248-255.
14. Tamburino C, Bleiziffer S, Thiele H, et al. Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial. Circulation, 2020, 142(25): 2431-2442.
15. Buono A, Gorla R, Ielasi A, et al. Transcatheter aortic valve replacement with self-expanding ACURATE neo2: postprocedural hemodynamic and short-term clinical outcomes. JACC Cardiovasc Interv, 2022, 15(11): 1101-1110.
16. Zhou D, Pan W, Wang J, et al. VitaFlow^TM transcatheter valve system in the treatment of severe aortic stenosis: one-year results of a multicenter study. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
17. 杨力凡, 张晓春, 张蕾, 等. VitaFlow^TM 经导管瓣膜系统治疗重度主动脉瓣狭窄—多中心 2 年随访结果. 中国介入心脏病学杂志, 2020, 28(6): 316-320.
18. 宋光远, 王墨扬, 王媛, 等. Venus-A 主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果. 中华心血管病杂志, 2017, 45(10): 843-847.
19. Wang M, Song G, Chen M, et al. Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis. EuroIntervention, 2022, 17(13): 1070-1076.
20. Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol, 2017, 70(22): 2752-2763.
21. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. Ann Thorac Surg, 2021, 111(2): 701-722.
22. Kempfert J, Rastan AJ, Mohr FW, et al. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve^TM. Eur J Cardiothorac Surg, 2011, 40(3): 761-763.
23. Nijenhuis VJ, Swaans MJ, Michiels V, et al. “First experience with JenaValve^TM: a single-centre cohort”. Neth Heart J, 2015, 23(1): 35-41.
24. Schäfer U, Schirmer J, Niklas S, et al. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EuroIntervention, 2017, 13(11): 1296-1299.
25. Vahl T, Makkar R, Kodali S, et al. 30-day outcomes of transfemoral transcatheter aortic valve replacement for aortic regurgitation with a novel self-expanding prosthesis. J Am Coll Cardiol, 2021, 77(18): 919.
26. Shi J, Wei L, Chen Y, et al. Transcatheter aortic valve implantation with J-Valve: 2-year outcomes from a multicenter study. Ann Thorac Surg, 2021, 111(5): 1530-1536.
27. Hensey M, Murdoch DJ, Sathananthan J, et al. First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system. EuroIntervention, 2019, 14(15): e1553-e1555.
28. Rezvova MA, Yuzhalin AE, Glushkova TV, et al. Biocompatible nanocomposites based on poly(styrene-block-isobutylene-block-styrene) and carbon nanotubes for biomedical application. Polymers (Basel), 2020, 12(9): 2158.
29. Rezvova MA, Nikishau PA, Makarevich MI, et al. Biomaterials based on carbon nanotube nanocomposites of poly(styrene-b-isobutylene-bstyrene): the effect of nanotube content on the mechanical properties, biocompatibility and hemocompatibility. Nanomaterials, 2022, 12(5): 733.
30. Bui HT, Khair N, Yeats B, et al. Transcatheter heart valves: a biomaterials perspective. Adv Healthc Mater, 2021, 10(15): 2100115.
31. Li RL, Russ J, Paschalides C, et al. Mechanical considerations for polymeric heart valve development: biomechanics, materials, design and manufacturing. Biomaterials, 2019, 225: 119493.
32. Oveissi F, Naficy S, Lee A, et al. Materials and manufacturing perspectives in engineering heart valves: a review. Mater Today Bio, 2020, 5: 100038.
33. Kereiakes DJ, Answini GA, Yakubov SJ, et al. Preliminary evaluation of a novel polymeric valve following surgical implantation for symptomatic aortic valve disease. JACC Cardiovasc Interv, 2021, 14(24): 2754-2756.

West China Medical Journal

Research progress of transcatheter aortic valve replacement-related new valve prostheses

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content